The University of Chicago Header Logo

Connection

Valluvan Jeevanandam to Middle Aged

Back to Details
This is a "connection" page, showing publications Valluvan Jeevanandam has written about Middle Aged.
Valluvan Jeevanandam
Connection Strength
2.129
Middle Aged
  1. Impact of plasma volume status on mortality following left ventricular assist device implantation. Artif Organs. 2021 Jun; 45(6):587-592.
    View in: PubMed
    Score: 0.051
  2. An International Study on Ventricular Assist Device Program Models. Prog Transplant. 2020 12; 30(4):355-359.
    View in: PubMed
    Score: 0.050
  3. Perioperative improvement in serum albumin level in patients with left ventricular assist device. J Card Surg. 2020 Nov; 35(11):3070-3077.
    View in: PubMed
    Score: 0.050
  4. Winter LVAD implantation is associated with adverse clinical outcomes. Int J Artif Organs. 2021 Mar; 44(3):188-193.
    View in: PubMed
    Score: 0.050
  5. An international survey: Tobacco smoking cessation strategies within left ventricular assist device centers. Int J Artif Organs. 2021 Feb; 44(2):110-114.
    View in: PubMed
    Score: 0.050
  6. Sex difference in the impact of smoking on left ventricular assist device outcomes. J Card Surg. 2020 Nov; 35(11):2913-2919.
    View in: PubMed
    Score: 0.050
  7. Opioid Use and Morbidities during Left Ventricular Assist Device Support. Int Heart J. 2020 May 30; 61(3):547-552.
    View in: PubMed
    Score: 0.049
  8. Effect of tobacco smoking on outcomes after left ventricular assist device implantation. Artif Organs. 2020 Jul; 44(7):693-699.
    View in: PubMed
    Score: 0.048
  9. The first-in-human experience with a minimally invasive, ambulatory, counterpulsation heart assist system for advanced congestive heart failure. J Heart Lung Transplant. 2018 01; 37(1):1-6.
    View in: PubMed
    Score: 0.041
  10. Atrial Arrhythmias and Electroanatomical Remodeling in Patients With Left Ventricular Assist Devices. J Am Heart Assoc. 2017 Mar 08; 6(3).
    View in: PubMed
    Score: 0.039
  11. Invasive Hemodynamic Echocardiographic Ramp Test in the HeartAssist5 LVAD: Insights into Device Performance. ASAIO J. 2017 Mar/Apr; 63(2):e10-e12.
    View in: PubMed
    Score: 0.039
  12. Complex Tricuspid Valve Repair in Patients With Pacer Defibrillator-Related Tricuspid Regurgitation. Ann Thorac Surg. 2016 Apr; 101(4):1599-601.
    View in: PubMed
    Score: 0.037
  13. Prophylactic Subclavian Artery Intraaortic Balloon Counter-Pulsation is Safe in High-Risk Cardiac Surgery Patients. ASAIO J. 2015 Sep-Oct; 61(5):e36-9.
    View in: PubMed
    Score: 0.036
  14. The Subclavian Intraaortic Balloon Pump: A Compelling Bridge Device for Advanced Heart Failure. Ann Thorac Surg. 2015 Dec; 100(6):2151-7; discussion 2157-8.
    View in: PubMed
    Score: 0.035
  15. Cardiovascular surgery in Jehovah's Witness patients: The role of preoperative optimization. J Thorac Cardiovasc Surg. 2015 Oct; 150(4):976-83.e1-3.
    View in: PubMed
    Score: 0.035
  16. Durability of De Vega tricuspid valve annuloplasty for severe tricuspid regurgitation during left ventricular assist device implantation. Ann Thorac Surg. 2014 Jul; 98(1):81-3.
    View in: PubMed
    Score: 0.032
  17. Transapical approach for mitral valve repair during insertion of a left ventricular assist device. ScientificWorldJournal. 2013; 2013:925310.
    View in: PubMed
    Score: 0.031
  18. Beating heart totally endoscopic coronary artery bypass. Ann Thorac Surg. 2010 Jun; 89(6):1873-9; discussion 1879-80.
    View in: PubMed
    Score: 0.025
  19. Reversal of impaired myocardial beta-adrenergic receptor signaling by continuous-flow left ventricular assist device support. J Heart Lung Transplant. 2010 Jun; 29(6):603-9.
    View in: PubMed
    Score: 0.024
  20. Donor tricuspid annuloplasty during orthotopic heart transplantation: long-term results of a prospective controlled study. Ann Thorac Surg. 2006 Dec; 82(6):2089-95; discussion 2095.
    View in: PubMed
    Score: 0.019
  21. Failure modes of left ventricular reconstruction or the Dor procedure: a multi-institutional perspective. Eur J Cardiothorac Surg. 2006 Aug; 30(2):347-52.
    View in: PubMed
    Score: 0.019
  22. A one-year comparison of prophylactic donor tricuspid annuloplasty in heart transplantation. Ann Thorac Surg. 2004 Sep; 78(3):759-66; discussion 759-66.
    View in: PubMed
    Score: 0.017
  23. Current state of intraoperative echocardiography. Echocardiography. 2003 Nov; 20(8):771-80.
    View in: PubMed
    Score: 0.016
  24. Rigid sternal fixation in the cardiac transplant population. J Thorac Cardiovasc Surg. 2003 Sep; 126(3):896-7.
    View in: PubMed
    Score: 0.015
  25. The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices. Artif Organs. 2023 Mar; 47(3):574-581.
    View in: PubMed
    Score: 0.015
  26. Circulatory assistance with a permanent implantable IABP: initial human experience. Circulation. 2002 Sep 24; 106(12 Suppl 1):I183-8.
    View in: PubMed
    Score: 0.014
  27. Implications of Heart Rate in Patients with Left Ventricular Assist Devices. Int Heart J. 2022; 63(1):56-61.
    View in: PubMed
    Score: 0.014
  28. Simultaneous Heart-Liver Transplantation for Congenital Heart Disease in the United States: Rapidly Increasing With Acceptable Outcomes. Hepatology. 2021 04; 73(4):1464-1477.
    View in: PubMed
    Score: 0.013
  29. Discordance between lactic acidemia and hemodynamics in patients with advanced heart failure. Clin Cardiol. 2021 May; 44(5):636-645.
    View in: PubMed
    Score: 0.013
  30. Short-Term Ventricular Structural Changes Following Left Ventricular Assist Device Implantation. ASAIO J. 2021 02 01; 67(2):169-176.
    View in: PubMed
    Score: 0.013
  31. Increased Rate of Pump Thrombosis and Cardioembolic Events Following Ventricular Tachycardia Ablation in Patients Supported With Left Ventricular Assist Devices. ASAIO J. 2020 Nov/Dec; 66(10):1127-1136.
    View in: PubMed
    Score: 0.013
  32. Impact of worsening of aortic insufficiency during HeartMate 3 LVAD support. Artif Organs. 2021 Mar; 45(3):297-302.
    View in: PubMed
    Score: 0.013
  33. Changes in regional myocardial function after coronary artery bypass graft surgery are predicted by intraoperative low-dose dobutamine echocardiography. Anesthesiology. 2000 Sep; 93(3):685-92.
    View in: PubMed
    Score: 0.013
  34. Outcomes of Ambulatory Axillary Intraaortic Balloon Pump as a Bridge to Heart Transplantation. Ann Thorac Surg. 2021 04; 111(4):1264-1270.
    View in: PubMed
    Score: 0.013
  35. Neurohormonal Blockade During Left Ventricular Assist Device Support. ASAIO J. 2020 08; 66(8):881-885.
    View in: PubMed
    Score: 0.012
  36. Optimal cannula positioning of HeartMate 3 left ventricular assist device. Artif Organs. 2020 Dec; 44(12):e509-e519.
    View in: PubMed
    Score: 0.012
  37. Clinical Outcomes and Quality of Life With an Ambulatory Counterpulsation Pump in Advanced Heart Failure Patients: Results of the Multicenter Feasibility Trial. Circ Heart Fail. 2020 04; 13(4):e006666.
    View in: PubMed
    Score: 0.012
  38. Hemodynamic Effects of Concomitant Mitral Valve Surgery and Left Ventricular Assist Device Implantation. ASAIO J. 2020 04; 66(4):355-361.
    View in: PubMed
    Score: 0.012
  39. Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures Is Associated With Right Ventricular Dysfunction and Hemocompatibility-Related Adverse Events in Patients With Left Ventricular Assist Devices. J Am Heart Assoc. 2020 04 07; 9(7):e014801.
    View in: PubMed
    Score: 0.012
  40. Short-Term Efficacy and Safety of Tolvaptan in Patients with Left Ventricular Assist Devices. ASAIO J. 2020 03; 66(3):253-257.
    View in: PubMed
    Score: 0.012
  41. Effect of Concomitant Tricuspid Valve Surgery With Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2020 09; 110(3):918-924.
    View in: PubMed
    Score: 0.012
  42. HeartWare Ventricular Assist Device Cannula Position and Hemocompatibility-Related Adverse Events. Ann Thorac Surg. 2020 09; 110(3):911-917.
    View in: PubMed
    Score: 0.012
  43. Longitudinal Trajectories of Hemodynamics Following Left Ventricular Assist Device Implantation. J Card Fail. 2020 May; 26(5):383-390.
    View in: PubMed
    Score: 0.012
  44. HVAD Flow Waveform Estimates Left Ventricular Filling Pressure. J Card Fail. 2020 Apr; 26(4):342-348.
    View in: PubMed
    Score: 0.012
  45. Outcomes following left ventricular assist device exchange. J Card Surg. 2020 Mar; 35(3):591-597.
    View in: PubMed
    Score: 0.012
  46. Deep Y-Descent in Right Atrial Waveforms Following Left Ventricular Assist Device Implantation. J Card Fail. 2020 Apr; 26(4):360-367.
    View in: PubMed
    Score: 0.012
  47. Estimation of Central Venous Pressure by Pacemaker Lead Impedances in Left Ventricular Assist Device Patients. ASAIO J. 2020 01; 66(1):49-54.
    View in: PubMed
    Score: 0.012
  48. Combined Left Ventricular Assist Device and Coronary Artery Bypass Grafting Surgery: Should We Bypass the Bypass? ASAIO J. 2020 01; 66(1):32-37.
    View in: PubMed
    Score: 0.012
  49. Omega-3 and hemocompatibility-related adverse events. J Card Surg. 2020 Feb; 35(2):405-412.
    View in: PubMed
    Score: 0.012
  50. Surgical device exchange provides improved clinical outcomes compared to medical therapy in treating continuous-flow left ventricular assist device thrombosis. Artif Organs. 2020 Apr; 44(4):367-374.
    View in: PubMed
    Score: 0.012
  51. Estimation of the Severity of Aortic Insufficiency by HVAD Flow Waveform. Ann Thorac Surg. 2020 03; 109(3):945-949.
    View in: PubMed
    Score: 0.012
  52. Metabolic Dysfunction in Continuous-Flow Left Ventricular Assist Devices Patients and Outcomes. J Am Heart Assoc. 2019 11 19; 8(22):e013278.
    View in: PubMed
    Score: 0.012
  53. Hemodynamics of concomitant tricuspid valve procedures at LVAD implantation. J Card Surg. 2019 Dec; 34(12):1511-1518.
    View in: PubMed
    Score: 0.012
  54. Increasing heart transplant donor pool by liberalization of size matching. J Heart Lung Transplant. 2019 11; 38(11):1197-1205.
    View in: PubMed
    Score: 0.012
  55. Discordance Between Clinical Assessment and Invasive Hemodynamics in Patients With Advanced Heart Failure. J Card Fail. 2020 Feb; 26(2):128-135.
    View in: PubMed
    Score: 0.012
  56. Aortic Insufficiency and Hemocompatibility-related Adverse Events in Patients with Left Ventricular Assist Devices. J Card Fail. 2019 Oct; 25(10):787-794.
    View in: PubMed
    Score: 0.012
  57. Molecular Mechanism of the Association Between Atrial Fibrillation and Heart Failure Includes Energy Metabolic Dysregulation Due to Mitochondrial Dysfunction. J Card Fail. 2019 Nov; 25(11):911-920.
    View in: PubMed
    Score: 0.012
  58. Novel Formula to Calculate Three-Dimensional Angle Between Inflow Cannula and Device Body of HeartMate II LVAD. Ann Thorac Surg. 2020 01; 109(1):63-68.
    View in: PubMed
    Score: 0.012
  59. Simultaneous heart, liver and kidney transplantation: A viable option for heart failure patients with multiorgan failure. J Heart Lung Transplant. 2019 09; 38(9):997-999.
    View in: PubMed
    Score: 0.012
  60. Association of Inflow Cannula Position with Left Ventricular Unloading and Clinical Outcomes in Patients with HeartMate II Left Ventricular Assist Device. ASAIO J. 2019 May/Jun; 65(4):331-335.
    View in: PubMed
    Score: 0.011
  61. A subcostal approach is favorable compared to sternotomy for left ventricular assist device exchange field of research: artificial heart (clinical). J Artif Organs. 2019 Sep; 22(3):181-187.
    View in: PubMed
    Score: 0.011
  62. A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. N Engl J Med. 2019 04 25; 380(17):1618-1627.
    View in: PubMed
    Score: 0.011
  63. Outflow Cannula Systolic Slope in Patients With Left Ventricular Assist Devices: A Novel Marker of Myocardial Contractility. ASAIO J. 2019 02; 65(2):160-166.
    View in: PubMed
    Score: 0.011
  64. Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates. Circ Heart Fail. 2019 02; 12(2):e005094.
    View in: PubMed
    Score: 0.011
  65. Home Inotropes in Patients Supported with Left Ventricular Assist Devices. ASAIO J. 2019 01; 65(1):e7-e11.
    View in: PubMed
    Score: 0.011
  66. Optimal haemodynamics during left ventricular assist device support are associated with reduced haemocompatibility-related adverse events. Eur J Heart Fail. 2019 05; 21(5):655-662.
    View in: PubMed
    Score: 0.011
  67. Feasibility and utility of intraoperative epicardial scar characterization during left ventricular assist device implantation. J Cardiovasc Electrophysiol. 2019 02; 30(2):183-192.
    View in: PubMed
    Score: 0.011
  68. Intraoperative Use of Nondepolarizing Neuromuscular Blocking Agents During Cardiac Surgery and Postoperative Pulmonary Complications: A Prospective Randomized Trial. J Cardiothorac Vasc Anesth. 2019 Jun; 33(6):1673-1681.
    View in: PubMed
    Score: 0.011
  69. Improvement in Biventricular Cardiac Function After Ambulatory Counterpulsation. J Card Fail. 2019 Jan; 25(1):20-26.
    View in: PubMed
    Score: 0.011
  70. Repeated Ramp Tests on Stable LVAD Patients Reveal Patient-Specific Hemodynamic Fingerprint. ASAIO J. 2018 Nov/Dec; 64(6):701-707.
    View in: PubMed
    Score: 0.011
  71. Laparoscopic procedures in patients with cardiac ventricular assist devices. Surg Endosc. 2019 07; 33(7):2181-2186.
    View in: PubMed
    Score: 0.011
  72. Left Atrial Appendage Occlusion With Left Ventricular Assist Device Decreases Thromboembolic Events. Ann Thorac Surg. 2019 04; 107(4):1181-1186.
    View in: PubMed
    Score: 0.011
  73. Omega-3 Therapy Is Associated With Reduced Gastrointestinal Bleeding in Patients With Continuous-Flow Left Ventricular Assist Device. Circ Heart Fail. 2018 10; 11(10):e005082.
    View in: PubMed
    Score: 0.011
  74. Incidence and Outcomes of Postoperative Atrial Fibrillation After Left Ventricular Assist Device. ASAIO J. 2018 Sep/Oct; 64(5):581-585.
    View in: PubMed
    Score: 0.011
  75. Impact of Residual Valve Disease on Survival After Implantation of Left Ventricular Assist Devices. Ann Thorac Surg. 2018 12; 106(6):1789-1796.
    View in: PubMed
    Score: 0.011
  76. Decoupling Between Diastolic Pulmonary Arterial Pressure and Pulmonary Arterial Wedge Pressure at Incremental Left Ventricular Assist Device (LVAD) Speeds Is Associated With Worse Prognosis After LVAD Implantation. J Card Fail. 2018 Sep; 24(9):575-582.
    View in: PubMed
    Score: 0.011
  77. Residual native left ventricular function optimization using quantitative 3D echocardiographic assessment of rotational mechanics in patients with left ventricular assist devices. Echocardiography. 2018 10; 35(10):1606-1615.
    View in: PubMed
    Score: 0.011
  78. Echocardiographic Predictors of Hemodynamics in Patients Supported With Left Ventricular Assist Devices. J Card Fail. 2018 Sep; 24(9):561-567.
    View in: PubMed
    Score: 0.011
  79. HVAD: The ENDURANCE Supplemental Trial. JACC Heart Fail. 2018 09; 6(9):792-802.
    View in: PubMed
    Score: 0.011
  80. Increase in short-term risk of rejection in heart transplant patients receiving granulocyte colony-stimulating factor. J Heart Lung Transplant. 2018 11; 37(11):1322-1328.
    View in: PubMed
    Score: 0.011
  81. Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med. 2018 Apr 12; 378(15):1386-1395.
    View in: PubMed
    Score: 0.011
  82. Increased Risk of Bleeding in Left Ventricular Assist Device Patients Treated with Enoxaparin as Bridge to Therapeutic International Normalized Ratio. ASAIO J. 2018 Mar/Apr; 64(2):140-146.
    View in: PubMed
    Score: 0.011
  83. The C-Port Distal Coronary Anastomotic Device Is Comparable With a Hand-Sewn Anastomosis: Human Histological Case Study. Innovations (Phila). 2018 Mar/Apr; 13(2):140-143.
    View in: PubMed
    Score: 0.011
  84. Preoperative Right-Sided Cardiac Congestion Is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices. Dig Dis Sci. 2018 Jun; 63(6):1518-1524.
    View in: PubMed
    Score: 0.011
  85. Can I Go Home With That Balloon Pump? J Cardiothorac Vasc Anesth. 2018 06; 32(3):1468-1479.
    View in: PubMed
    Score: 0.011
  86. Predictors of Hemodynamic Improvement and Stabilization Following Intraaortic Balloon Pump Implantation in Patients With Advanced Heart Failure. J Invasive Cardiol. 2018 02; 30(2):56-61.
    View in: PubMed
    Score: 0.010
  87. Consequences of Retained Defibrillator and Pacemaker Leads After Heart Transplantation-An Underrecognized Problem. J Card Fail. 2018 02; 24(2):101-108.
    View in: PubMed
    Score: 0.010
  88. The role of gender in heart transplantation. Ann Thorac Surg. 1998 Jan; 65(1):88-94.
    View in: PubMed
    Score: 0.010
  89. HVAD Waveform Analysis as a Noninvasive Marker of Pulmonary Capillary Wedge Pressure: A First Step Toward the Development of a Smart Left Ventricular Assist Device Pump. ASAIO J. 2018 Jan/Feb; 64(1):10-15.
    View in: PubMed
    Score: 0.010
  90. Cannula and Pump Positions Are Associated With Left Ventricular Unloading and Clinical Outcome in Patients With HeartWare Left Ventricular Assist Device. J Card Fail. 2018 03; 24(3):159-166.
    View in: PubMed
    Score: 0.010
  91. Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation. Circ Heart Fail. 2017 Sep; 10(9).
    View in: PubMed
    Score: 0.010
  92. Characterization of Ventricular Tachycardia After Left Ventricular Assist Device Implantation as Destination Therapy: A Single-Center Ablation Experience. JACC Clin Electrophysiol. 2017 12 11; 3(12):1412-1424.
    View in: PubMed
    Score: 0.010
  93. Report From the American Society of Transplantation Conference on Donor Heart Selection in Adult Cardiac Transplantation in the United States. Am J Transplant. 2017 Oct; 17(10):2559-2566.
    View in: PubMed
    Score: 0.010
  94. Accepting Hearts From Hepatitis C-Positive Donor: Can We Expand the Donor Pool? J Card Fail. 2017 Oct; 23(10):762-764.
    View in: PubMed
    Score: 0.010
  95. Tumor necrosis factor-a levels and non-surgical bleeding in continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2018 01; 37(1):107-115.
    View in: PubMed
    Score: 0.010
  96. The Hemodynamic Effects of Aortic Insufficiency in Patients Supported With Continuous-Flow Left Ventricular Assist Devices. J Card Fail. 2017 Jul; 23(7):545-551.
    View in: PubMed
    Score: 0.010
  97. 3D Morphological Changes in LV and RV During LVAD Ramp Studies. JACC Cardiovasc Imaging. 2018 02; 11(2 Pt 1):159-169.
    View in: PubMed
    Score: 0.010
  98. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. Circulation. 2017 May 23; 135(21):2003-2012.
    View in: PubMed
    Score: 0.010
  99. Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure. N Engl J Med. 2017 02 02; 376(5):451-460.
    View in: PubMed
    Score: 0.010
  100. Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function. Clin Transplant. 1996 Dec; 10(6 Pt 2):639-45.
    View in: PubMed
    Score: 0.010
  101. Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg. 1996 Nov; 62(5):1268-75.
    View in: PubMed
    Score: 0.010
  102. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation. 1996 Nov 01; 94(9 Suppl):II227-34.
    View in: PubMed
    Score: 0.010
  103. Surgically Corrected Mitral Regurgitation During Left Ventricular Assist Device Implantation Is Associated With Low Recurrence Rate and Improved Midterm Survival. Ann Thorac Surg. 2017 Mar; 103(3):725-733.
    View in: PubMed
    Score: 0.010
  104. Defining the role of aprotinin in heart transplantation. Ann Thorac Surg. 1996 Sep; 62(3):670-4.
    View in: PubMed
    Score: 0.010
  105. Elevated Angiopoietin-2 Level in Patients With Continuous-Flow Left Ventricular Assist Devices Leads to Altered Angiogenesis and Is Associated With Higher Nonsurgical Bleeding. Circulation. 2016 Jul 12; 134(2):141-52.
    View in: PubMed
    Score: 0.009
  106. Left Ventricular Assist Device Deactivation via Percutaneous Closure of the Outflow Graft. J Card Fail. 2016 Aug; 22(8):653-5.
    View in: PubMed
    Score: 0.009
  107. Screening for Outflow Cannula Malfunction of Left Ventricular Assist Devices (LVADs) With the Use of Doppler Echocardiography: New LVAD-Specific Reference Values for Contemporary Devices. J Card Fail. 2016 Oct; 22(10):808-14.
    View in: PubMed
    Score: 0.009
  108. PCI in Patients Supported With CF-LVADs: Indications, Safety, and Outcomes. J Invasive Cardiol. 2016 Jun; 28(6):238-42.
    View in: PubMed
    Score: 0.009
  109. Recipient-donor atrial synchronization benefits acute hemodynamics after orthotopic heart transplantation. J Heart Lung Transplant. 1996 Apr; 15(4):368-70.
    View in: PubMed
    Score: 0.009
  110. Sequential Organ Failure Assessment Score at Presentation Predicts Survival in Patients Treated With Percutaneous Veno-Arterial Extracorporeal Membrane Oxygenation. J Invasive Cardiol. 2016 Apr; 28(4):133-8.
    View in: PubMed
    Score: 0.009
  111. Hemodynamic Ramp Tests in Patients With Left Ventricular Assist Devices. JACC Heart Fail. 2016 Mar; 4(3):208-17.
    View in: PubMed
    Score: 0.009
  112. Elongation of chordae tendineae as an adaptive process to reduce mitral regurgitation in functional mitral regurgitation. Eur Heart J Cardiovasc Imaging. 2016 May; 17(5):500-9.
    View in: PubMed
    Score: 0.009
  113. Accurate Quantification Methods for Aortic Insufficiency Severity in Patients With LVAD: Role of Diastolic Flow Acceleration and Systolic-to-Diastolic Peak Velocity Ratio of Outflow Cannula. JACC Cardiovasc Imaging. 2016 06; 9(6):641-51.
    View in: PubMed
    Score: 0.009
  114. Predictors of survival following trans-catheter aortic valve closure for left ventricular assist device associated aortic insufficiency. Catheter Cardiovasc Interv. 2016 Apr; 87(5):971-9.
    View in: PubMed
    Score: 0.009
  115. Leaflet-chordal relations in patients with primary and secondary mitral regurgitation. J Am Soc Echocardiogr. 2015 Nov; 28(11):1302-8.
    View in: PubMed
    Score: 0.009
  116. Surgical management of cardiac pheochromocytoma. Resection versus transplantation. Ann Surg. 1995 Apr; 221(4):415-9.
    View in: PubMed
    Score: 0.009
  117. Gastrointestinal bleeding in recipients of the HeartWare Ventricular Assist System. JACC Heart Fail. 2015 Apr; 3(4):303-13.
    View in: PubMed
    Score: 0.009
  118. Visualization and measurement of mitral valve chordae tendineae using three-dimensional transesophageal echocardiography from the transgastric approach. J Am Soc Echocardiogr. 2015 Apr; 28(4):449-54.
    View in: PubMed
    Score: 0.009
  119. Can Intraoperative Transesophageal Echocardiography Predict Postoperative Aortic Insufficiency in Patients Receiving Implantable Left Ventricular Assist Devices? J Cardiothorac Vasc Anesth. 2015 Aug; 29(4):901-5.
    View in: PubMed
    Score: 0.008
  120. Adult orthotopic heart transplantation using undersized pediatric donor hearts. Technique and postoperative management. Circulation. 1994 Nov; 90(5 Pt 2):II74-7.
    View in: PubMed
    Score: 0.008
  121. Positional obstruction of the superior mesenteric artery by an intra-aortic balloon pump placed through subclavian artery approach. Circ Heart Fail. 2014 Sep; 7(5):864-7.
    View in: PubMed
    Score: 0.008
  122. Impact of implantable transvenous device lead location on severity of tricuspid regurgitation. J Am Soc Echocardiogr. 2014 Nov; 27(11):1164-75.
    View in: PubMed
    Score: 0.008
  123. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation. JACC Cardiovasc Imaging. 2014 Apr; 7(4):337-47.
    View in: PubMed
    Score: 0.008
  124. Acute kidney injury and mortality following ventricular assist device implantation. Am J Nephrol. 2014; 39(3):195-203.
    View in: PubMed
    Score: 0.008
  125. Mitral valve dynamics in severe aortic stenosis before and after aortic valve replacement. J Am Soc Echocardiogr. 2013 Jun; 26(6):606-14.
    View in: PubMed
    Score: 0.008
  126. Localizing mitral valve perforations with 3D transesophageal echocardiography. JACC Cardiovasc Imaging. 2013 Mar; 6(3):407-10.
    View in: PubMed
    Score: 0.007
  127. Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics. JACC Cardiovasc Interv. 2013 Jan; 6(1):84-9.
    View in: PubMed
    Score: 0.007
  128. The implantable defibrillator: an electronic bridge to cardiac transplantation. Circulation. 1992 Nov; 86(5 Suppl):II276-9.
    View in: PubMed
    Score: 0.007
  129. Percutaneous transcatheter closure of the aortic valve to treat cardiogenic shock in a left ventricular assist device patient with severe aortic insufficiency. Ann Thorac Surg. 2012 Sep; 94(3):985-8.
    View in: PubMed
    Score: 0.007
  130. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012 Jun 26; 125(25):3191-200.
    View in: PubMed
    Score: 0.007
  131. Intra-aortic balloon pump inserted through the subclavian artery: A minimally invasive approach to mechanical support in the ambulatory end-stage heart failure patient. J Thorac Cardiovasc Surg. 2012 Oct; 144(4):951-5.
    View in: PubMed
    Score: 0.007
  132. Quantifying the incremental cost of complications associated with mitral valve surgery in the United States. J Thorac Cardiovasc Surg. 2012 Apr; 143(4):864-72.
    View in: PubMed
    Score: 0.007
  133. Percutaneous transcatheter closure of the native aortic valve to treat de novo aortic insufficiency after implantation of a left ventricular assist device. JACC Cardiovasc Interv. 2012 Mar; 5(3):358-9.
    View in: PubMed
    Score: 0.007
  134. University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation. A randomized blinded prospective clinical trial. J Thorac Cardiovasc Surg. 1992 Feb; 103(2):194-8; discussion 198-9.
    View in: PubMed
    Score: 0.007
  135. University of Wisconsin solution for human donor heart preservation: initial clinical experience. Ann Thorac Surg. 1991 Dec; 52(6):1213-6.
    View in: PubMed
    Score: 0.007
  136. Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors. Ann Thorac Surg. 2011 Aug; 92(2):520-7; discussion 527.
    View in: PubMed
    Score: 0.007
  137. Aortic root and valve thrombosis after implantation of a left ventricular assist device. J Invasive Cardiol. 2011 Apr; 23(4):E63-5.
    View in: PubMed
    Score: 0.007
  138. Quantitative analysis of mitral valve apparatus in mitral valve prolapse before and after annuloplasty: a three-dimensional intraoperative transesophageal study. J Am Soc Echocardiogr. 2011 Apr; 24(4):405-13.
    View in: PubMed
    Score: 0.006
  139. Reasons for nonadherence to guidelines for aortic valve replacement in patients with severe aortic stenosis and potential solutions. Am J Cardiol. 2010 May 01; 105(9):1339-42.
    View in: PubMed
    Score: 0.006
  140. Activation of JAK-STAT and nitric oxide signaling as a mechanism for donor heart dysfunction. J Heart Lung Transplant. 2010 Mar; 29(3):346-51.
    View in: PubMed
    Score: 0.006
  141. Real-time three-dimensional transesophageal echocardiography in valve disease: comparison with surgical findings and evaluation of prosthetic valves. J Am Soc Echocardiogr. 2008 Dec; 21(12):1347-54.
    View in: PubMed
    Score: 0.006
  142. Live 3-dimensional transesophageal echocardiography initial experience using the fully-sampled matrix array probe. J Am Coll Cardiol. 2008 Aug 05; 52(6):446-9.
    View in: PubMed
    Score: 0.005
  143. Current state of combined heart-liver transplantation in the United States. J Heart Lung Transplant. 2008 Jul; 27(7):753-9.
    View in: PubMed
    Score: 0.005
  144. Images in cardiovascular medicine. Subaortic membrane in the adult. Circulation. 2005 Dec 06; 112(23):e347.
    View in: PubMed
    Score: 0.005
  145. Primary sternal plating in high-risk patients prevents mediastinitis. Eur J Cardiothorac Surg. 2004 Aug; 26(2):367-72.
    View in: PubMed
    Score: 0.004
  146. Identical alpha-chain T-cell receptor transcripts are present on T cells infiltrating coronary arteries of human cardiac allografts with chronic rejection. Cell Immunol. 2003 Oct; 225(2):75-90.
    View in: PubMed
    Score: 0.004
  147. Dynamic three-dimensional color flow Doppler: an improved technique for the assessment of mitral regurgitation. Echocardiography. 2003 Apr; 20(3):265-73.
    View in: PubMed
    Score: 0.004
  148. Papillary fibroelastoma of the aortic valve. J Am Soc Echocardiogr. 2002 Apr; 15(4):382-4.
    View in: PubMed
    Score: 0.004
  149. Apoptosis in chronic rejection of human cardiac allografts. Transplantation. 2001 Apr 27; 71(8):1137-46.
    View in: PubMed
    Score: 0.003
  150. Open cardiotomy for removal of migrating transjugular intrahepatic portosystemic shunt stent combined with liver transplantation. Transplantation. 2001 Apr 15; 71(7):1000-3.
    View in: PubMed
    Score: 0.003
  151. Coronary arteries from human cardiac allografts with chronic rejection contain oligoclonal T cells: persistence of identical clonally expanded TCR transcripts from the early post-transplantation period (endomyocardial biopsies) to chronic rejection (coronary arteries). J Immunol. 2000 Sep 15; 165(6):3469-83.
    View in: PubMed
    Score: 0.003
  152. Balloon-expandable stent placement for superior vena cava-right atrial stenosis after heart transplantation. J Heart Lung Transplant. 2000 Jul; 19(7):705-9.
    View in: PubMed
    Score: 0.003
  153. L-type Ca2+ channel alpha 1c subunit isoform switching in failing human ventricular myocardium. J Mol Cell Cardiol. 2000 Jun; 32(6):973-84.
    View in: PubMed
    Score: 0.003
  154. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med. 1998 Dec 10; 339(24):1744-51.
    View in: PubMed
    Score: 0.003
  155. Regression of cellular hypertrophy after left ventricular assist device support. Circulation. 1998 Aug 18; 98(7):656-62.
    View in: PubMed
    Score: 0.003
  156. Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year. Transplant Proc. 1998 Aug; 30(5):1892-4.
    View in: PubMed
    Score: 0.003
  157. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation. 1998 Jun 16; 97(23):2316-22.
    View in: PubMed
    Score: 0.003
  158. Altered myocardial phenotype after mechanical support in human beings with advanced cardiomyopathy. J Heart Lung Transplant. 1997 Jul; 16(7):765-73.
    View in: PubMed
    Score: 0.003
  159. Eliminating bradyarrhythmias after orthotopic heart transplantation. Circulation. 1996 Nov 01; 94(9 Suppl):II278-82.
    View in: PubMed
    Score: 0.002
  160. Functional and morphologic adaptation of undersized donor hearts after heart transplantation. J Am Coll Cardiol. 1995 Sep; 26(3):737-42.
    View in: PubMed
    Score: 0.002
  161. Electrophysiologic effects of intravenous aminophylline in heart transplant recipients with sinus node dysfunction. J Heart Lung Transplant. 1995 May-Jun; 14(3):429-35.
    View in: PubMed
    Score: 0.002
  162. Endomyocardial biopsy under transesophageal echocardiographic guidance can be safely performed in the critically ill cardiac transplant recipient. Am J Cardiol. 1994 May 15; 73(13):1019-20.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.